SENSEX 260.30 0.36%
72664.47
 
NIFTY 97.70 0.44%
22055.20
 
Nasdaq -5.39 -0.03%
16340.87
 
Nikkei 225 155.13 0.41%
38229.11
 
FTSE 100 52.40 0.63%
8433.80
YOU ARE ON
IPO
Current Issues
Forthcoming Issues
Closed Issues
New Listings
Best Performers
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
Glenmark Life Sciences Ltd.
Issue Open Date 27-Jul-21  
Issue Closing Date 29-Jul-21  
Application Money 100  
Allotment Money  
Price Band 695 - 720  
Minimium Application No. 20  
Issue Size (Shares) 21022222  
Market Lot 1  
Objective
1. Payment of outstanding purchase consideration to the Promoter for the spin-off of the API business from the Promoter into our Company pursuant to the Business Purchase Agreement.2. Funding capital expenditure requirements.3. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   3232770   396129640   122.535670647773  
Qualified Institutional Buyers   4242379   156829300   36.9673006584277  
Retail Individual Investors   4242379   156829300   36.9673006584277  
Business Description
We are a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease (“CVS”), central nervous system disease (“CNS”), pain management and di
Promoter's Holding
Total Share Capital   131567217  
Offered to Public   21022222  
Promoter's Holding (Pre-Issue)   46.63  
Promoter's Holding (Post-Issue)   82.84  
MORE >
Address
Plot No. 170-172
Chandramouli Industrial Estate
Mohol Bazarpeth
Solapur ,
Maharashtra ,
413213
Phone : 02189 234456/234246
Email : complianceofficer@glenmarklifesciences.com
Website : www.glenmarklifesciences.com
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
BOB Capital Markets Ltd
BofA Securities India Ltd.
Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.)
Goldman Sachs (India) Securities Pvt Ltd
Kotak Mahindra Capital Co Ltd
SBI Capital Markets Ltd
Promoters
Glenmark Pharmaceuticals Ltd
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ADINATH COMMODITIES  :   COMMODITIES SEBI REGISTRATION NUMBERS : INZ000042629 MultiCommodity Exchange Ltd (MCX):Member ID -10140 National Commodity and Derivatives Exchange Ltd (NCDEX):Member ID -00622.
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By Accord Fintech Pvt.Ltd.